Sisram Medical Ltd

SEHK:1696 주식 보고서

시가총액: HK$1.9b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sisram Medical 관리

관리 기준 확인 2/4

Sisram Medical's CEO는 Lior Dayan, Jun2017 에 임명되었습니다 의 임기는 7.08 년입니다. 총 연간 보상은 $ 1.53M, 56.6% 로 구성됩니다. 56.6% 급여 및 43.4% 보너스(회사 주식 및 옵션 포함). 는 HK$ 3.38M 가치에 해당하는 회사 주식의 0.2% 직접 소유합니다. 3.38M. 경영진과 이사회의 평균 재임 기간은 각각 1.5 년과 6.9 년입니다.

주요 정보

Lior Dayan

최고 경영자

US$1.5m

총 보상

CEO 급여 비율56.6%
CEO 임기7.3yrs
CEO 소유권0.2%
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간7.2yrs

최근 관리 업데이트

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24
Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Apr 21
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Mar 28
Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Mar 05
Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Jan 23
Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Dec 29
Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Nov 09
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Oct 19
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sep 18
At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Aug 14
Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Jun 16
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30
Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01
Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12
Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21
Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01
Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14
Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28
Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01
Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03
Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11
If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17
Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22
Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22
Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27
Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24
Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

CEO 보상 분석

Lior Dayan 의 보수는 Sisram Medical 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$24m

Mar 31 2024n/an/a

US$28m

Dec 31 2023US$2mUS$863k

US$31m

Sep 30 2023n/an/a

US$35m

Jun 30 2023n/an/a

US$38m

Mar 31 2023n/an/a

US$39m

Dec 31 2022US$3mUS$1m

US$40m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$35m

Mar 31 2022n/an/a

US$33m

Dec 31 2021US$2mUS$767k

US$31m

Sep 30 2021n/an/a

US$28m

Jun 30 2021n/an/a

US$24m

Mar 31 2021n/an/a

US$19m

Dec 31 2020US$769kUS$596k

US$13m

Sep 30 2020n/an/a

US$13m

Jun 30 2020n/an/a

US$13m

Mar 31 2020n/an/a

US$17m

Dec 31 2019US$759kUS$606k

US$21m

Sep 30 2019n/an/a

US$22m

Jun 30 2019n/an/a

US$24m

Mar 31 2019n/an/a

US$23m

Dec 31 2018US$884kUS$560k

US$22m

Sep 30 2018n/an/a

US$18m

Jun 30 2018n/an/a

US$14m

Mar 31 2018n/an/a

US$12m

Dec 31 2017US$829kUS$361k

US$11m

보상 대 시장: Lior 의 총 보상 ($USD 1.53M )은 Hong Kong 시장( $USD 351.75K ).

보상과 수익: Lior 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Lior Dayan (54 yo)

7.3yrs

테뉴어

US$1,526,000

보상

Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...


리더십 팀

이름위치테뉴어보상소유권
Yi Liu
Executive Chairman8.5yrsUS$27.00k0.053%
$ 1.0m
Lior Dayan
President7.3yrsUS$1.53m0.20%
$ 3.8m
Doron Yannai
VP of Finance1.8yrs데이터 없음데이터 없음
Ran Ezioni
Chief Operating Officer6.5yrs데이터 없음데이터 없음
Nikol Lev
Chief Information Officerless than a year데이터 없음데이터 없음
Tal Rosen
Chief Marketing Officer1.8yrs데이터 없음데이터 없음
Orit Segal
Chief People Officer1.8yrs데이터 없음데이터 없음
Eyal David
President of ROW1.8yrs데이터 없음데이터 없음
Itay Meir
EVP of R&D1.8yrs데이터 없음데이터 없음
Keith Adams
President NA1.8yrs데이터 없음데이터 없음
Qianli Fang
Company Secretary2.8yrs데이터 없음데이터 없음

1.8yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: 1696 의 관리팀은 경험 (평균 재직 기간 1.4 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Yi Liu
Executive Chairman8.5yrsUS$27.00k0.053%
$ 1.0m
Lior Dayan
President7.3yrsUS$1.53m0.20%
$ 3.8m
Heung Sang Fong
Independent Non-Executive Director7.2yrsUS$32.00k데이터 없음
Yifang Wu
Non-Executive Director8yrs데이터 없음데이터 없음
Chi Fung Chan
Independent Non-Executive Director7.2yrsUS$32.00k데이터 없음
Jenny Chen
Independent Non-Executive Director7.2yrsUS$32.00k데이터 없음
Kai Yu Liu
Independent Non-Executive Director7.2yrsUS$32.00k데이터 없음
Rongli Feng
Non-Executive Director4.2yrs데이터 없음데이터 없음

7.2yrs

평균 재임 기간

51.5yo

평균 연령

경험이 풍부한 이사회: 1696 의 이사회경험(평균 재직 기간 6.8 년)으로 간주됩니다.